Disease | tuberous sclerosis |
Symptom | C0206731|angiofibromas |
Sentences | 12 |
PubMedID- 20403796 | Cryosurgery: an easy and cheap therapy for facial angiofibromas in tuberous sclerosis. |
PubMedID- 22934754 | The application of low-dose topical rapamycin (0.003–0.015%) to the face can safely decrease the appearance of facial angiofibromas in patients with tuberous sclerosis complex. |
PubMedID- 21861956 | Topical rapamycin solution to treat multiple facial angiofibromas in a patient with tuberous sclerosis. |
PubMedID- 25336102 | Laser treatment of angiofibromas in tuberous sclerosis. |
PubMedID- 22552000 | Giant angiofibromas in tuberous sclerosis complex: a possible role for localized lymphedema in their pathogenesis. |
PubMedID- 24890518 | Treatment of nodular facial angiofibromas in tuberous sclerosis, using ultrapulse carbon dioxide laser. |
PubMedID- 20698845 | Transforming growth factor-beta enhances matrix metalloproteinase-2 expression and activity through akt in fibroblasts derived from angiofibromas in patients with tuberous sclerosis complex. |
PubMedID- 22943457 | Interestingly, facial angiofibromas associated with tuberous sclerosis also have significantly improved with sirolimus therapy in a case report. |
PubMedID- 21410374 | Facial angiofibromas associated with tuberous sclerosis. |
PubMedID- 24401865 | Treatment of angiofibromas in tuberous sclerosis complex: the effect of topical rapamycin and concomitant laser therapy. |
PubMedID- 21931059 | Dramatic improvement of facial angiofibromas in tuberous sclerosis with topical rapamycin: optimizing a treatment protocol. |
PubMedID- 23909960 | Vehicle for facial angiofibromas in patients with tuberous sclerosis complex. |
Page: 1